Bollard Group LLC Stake In Boston Scientific Corp (BSX) Was Lifted

June 20, 2017 - By reb123z

Investors sentiment decreased to 0.84 in 2016 Q4. Its down 0.28, from 1.12 in 2016Q3. It worsened, as 67 investors sold BSX shares while 195 reduced holdings. 60 funds opened positions while 161 raised stakes. 1.23 billion shares or 1.80% more from 1.21 billion shares in 2016Q3 were reported. Cleararc has 33,071 shares. Ahl Limited Liability Partnership holds 24,857 shares or 0.02% of its portfolio. 2,000 are held by Amer Rech & Mgmt Communication. Natl Pension Ser has 0.16% invested in Boston Scientific Corporation (NYSE:BSX). Salem Invest Counselors Inc holds 0.28% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 113,846 shares. Eaton Vance Mngmt accumulated 26,719 shares or 0% of the stock. 38,253 were accumulated by Glenmede Tru Na. Palisade Asset Management Limited Liability accumulated 0.05% or 11,900 shares. Savings Bank Of America Corp De invested in 0.04% or 8.04 million shares. Davidson Kempner Capital LP owns 600,000 shares. Tci Wealth Advisors has invested 0.03% in Boston Scientific Corporation (NYSE:BSX). Cwm Limited Liability Co reported 0% stake. Louisiana State Employees Retirement holds 0.1% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 85,600 shares. Manufacturers Life Communication The owns 1.43M shares or 0.04% of their US portfolio. Schroder Investment Group holds 226,626 shares or 0.01% of its portfolio.

Since January 9, 2017, it had 0 insider buys, and 20 insider sales for $10.61 million activity. $588,846 worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Pratt Timothy A.. The insider Pierce David A sold $379,736. Thepaut Eric Francis Yves also sold $592,858 worth of Boston Scientific Corporation (NYSE:BSX) shares. 2,950 shares were sold by Sorenson John Bradley, worth $72,747 on Monday, April 10. $616,663 worth of stock was sold by Mirviss Jeffrey B. on Tuesday, February 28. The insider Dawkins Keith D sold 30,000 shares worth $739,134. 79,045 Boston Scientific Corporation (NYSE:BSX) shares with value of $1.94 million were sold by Phalen Michael P..

Bollard Group Llc increased its stake in Boston Scientific Corp (BSX) by 1.39% based on its latest 2016Q4 regulatory filing with the SEC. Bollard Group Llc bought 481,488 shares as the company’s stock rose 4.02% with the market. The hedge fund held 35.13 million shares of the medical and dental instruments company at the end of 2016Q4, valued at $759.91M, up from 34.65M at the end of the previous reported quarter. Bollard Group Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $38.69 billion market cap company. The stock increased 1.80% or $0.5 during the last trading session, reaching $28.25. About shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since June 20, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: which released: “Boston Scientific (BSX) Up 4.4% Since Earnings Report: Can It Continue?” on June 02, 2017, also with their article: “Boston Scientific to Participate in 2017 UBS Global Healthcare Conference” published on May 17, 2017, published: “Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)” on June 07, 2017. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: and their article: “Boston Scientific Trades Up on Strong Q1 amid Recall Issues” published on May 30, 2017 as well as‘s news article titled: “Boston Scientific (BSX) BT Study on Asthma Results Positive” with publication date: May 25, 2017.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 26 analysts covering Boston Scientific Corporation (NYSE:BSX), 20 have Buy rating, 0 Sell and 6 Hold. Therefore 77% are positive. Boston Scientific Corporation had 39 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Stifel Nicolaus on Thursday, April 28. The stock of Boston Scientific Corporation (NYSE:BSX) has “Corporate” rating given on Thursday, October 29 by FinnCap. The stock of Boston Scientific Corporation (NYSE:BSX) has “Outperform” rating given on Monday, August 10 by Credit Suisse. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, May 30 report. The stock has “Hold” rating by TheStreet on Thursday, August 13. Needham upgraded the stock to “Buy” rating in Monday, September 28 report. The rating was maintained by Needham with “Buy” on Friday, July 29. As per Thursday, February 25, the company rating was initiated by Suntrust Robinson. The firm has “Buy” rating given on Friday, April 28 by Needham. BTIG Research maintained the shares of BSX in report on Sunday, September 6 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.